Join the Influenza Prophylaxis group to help and get support from people like you.
Influenza Prophylaxis News (Page 3)
Related terms: Flu Prevention
Seqirus Receives FDA Approval for Afluria Quadrivalent (Influenza Vaccine) for People 18 Years of Age and Older
CAMBRIDGE, Mass., Aug. 29, 2016 /PRNewswire/ – Seqirus announced today that the US Food and Drug Administration (FDA) has approved Afluria Quadrivalent (Influenza Vaccine) for use in persons 18...
FDA Approves Fluad (influenza vaccine, adjuvanted) for Prevention of Seasonal Influenza
November 24, 2015 – The U.S. Food and Drug Administration today approved Fluad, the first seasonal influenza vaccine containing an adjuvant. Fluad, a trivalent vaccine produced from three influenza...
Sanofi Pasteur Announces FDA Approval Of Fluzone Intradermal Quadrivalent
SWIFTWATER, Pa., Dec. 12, 2014 /PRNewswire/ – Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration (FDA) has...
New Fluzone Quadrivalent Four-Strain Influenza Vaccine from Sanofi Pasteur Now Licensed By FDA for Broad Age Range of Children and Adults
• The first and only 4-strain influenza vaccine option for patients as young as six months of age, • Helps protect children and adults against additional influenza B strain, • Newes...
FDA Approves Flublok - New Seasonal Influenza Vaccine Made Using Novel Technology
January 16, 2013 – The U.S. Food and Drug Administration today announced that it has approved Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression...
FDA Expands Tamiflu's Use to Treat Children Younger Than One Year
December 21, 2012 – The U.S. Food and Drug Administration today expanded the approved use of Tamiflu (oseltamivir) to treat children as young as 2 weeks old who have shown symptoms of flu for no...
FDA Approves GlaxoSmithKline's Fluarix Quadrivalent - Four-strain Seasonal Influenza Vaccine for Use in the U.S.
LONDON, Dec. 17, 2012 /PRNewswire/ -- GlaxoSmithKline plc [LSE/NYSE: GSK] announced today that the U.S. Food and Drug Administration (FDA) has approved FLUARIX® QUADRIVALENT (Influenza Virus V...
FDA Approves Flucelvax - First Seasonal Influenza Vaccine Manufactured Using Cell Culture Technology
November 20, 2012 – The U.S. Food and Drug Administration announced today the approval of Flucelvax, the first seasonal influenza vaccine licensed in the United States produced using cultured animal...
FDA Licenses Fluzone Intradermal - Sanofi Pasteur's New Influenza Vaccine Delivered by Intradermal Microinjection
Swiftwater, Pa — May 10, 2011 /PRNewswire/ — Sanofi Pasteur, the vaccines division of Sanofi announced today the U.S. Food and Drug Administration (FDA) has approved the company's supplemental bio...
FDA Approves a High Dose Seasonal Influenza Vaccine Specifically Intended for People Ages 65 and Older
The U.S. Food and Drug Administration today approved Fluzone High-Dose, an inactivated influenza virus vaccine for people ages 65 years and older to prevent disease caused by influenza virus subtypes...
FDA Approves Agriflu Seasonal Influenza Vaccine
ROCKVILLE, Md., Nov. 27, 2009--The U.S. Food and Drug Administration today approved Agriflu for people ages 18 years and older to prevent disease caused by influenza virus subtypes A and B. Agriflu,...